Optimal Pre-treatment and Resolubilization of Protease B from Bacillus licheniformis

Article Sidebar

PDF
Published: Mar 30, 2018
Keywords:
Protein solubility, physical parameters, ultrafiltration concentrate, enzyme concentration, enzyme crystal.

Main Article Content

Sk. Amir Hossain*
Biotechnology and Genetic Engineering Discipline, Khulna University, Bangladesh
Andres Veide
School of Biotechnology, The Royal Institute of Technology (KTH), Sweden
Cecilia Janson Kapca
Department of Recovery Development, Novozymes A/S, Denmark
Kim Hanson Uhre
Department of Recovery Development, Novozymes A/S, Denmark
Sune Jakobsen
Department of Recovery Development, Novozymes A/S, Denmark

Abstract

The study was designed to optimize physical parameters (e.g., temperature, maturation time and pH) related to protein solubility in order to reduce the cost of the total process of the enzyme production at industrial scale. We have studied the influence of physical parameters and chemical pre-treatment on the solubility of Protease B in detail. Protease B, a recombinant proteolytic enzyme produced from genetically engineered Bacillus licheniformis was used in this study. A longer protein solubility region as a function of pH and dry matter percentage was found at 4°C for Protease B. The maximum dry matter percentage was 20.1% RI (Refractive Index). The optimum protein solubility for Protease B solubility was found between 3.0 to 4.0 mS/cm conductivity within a pH range of 4.0 to 6.0. The solubility trend of the protein was not changed by the level of the enzyme concentration. This study clearly demonstrates that optimization of some physical parameters and chemical pre-treatment improves the solubility of Protease B and thus establishes the conditions of parameters in a cost-effective strategy of Protease B recovery and production at industrial scale.
Keywords: Protein solubility, physical parameters, ultrafiltration concentrate, enzyme concentration, enzyme crystal.


*Corresponding author: Mobile: +880-1720478775


  E-mail: isti_99@yahoo.com.

Article Details

How to Cite
Hossain*, S. A., Veide, A., Janson Kapca, C., Uhre, K. H., & Jakobsen, S. (2018). Optimal Pre-treatment and Resolubilization of Protease B from Bacillus licheniformis. CURRENT APPLIED SCIENCE AND TECHNOLOGY, 11(1), 9–16. retrieved from https://li01.tci-thaijo.org/index.php/cast/article/view/136316
Issue
Vol. 11 No. 1 (2011)
Section
Review Ariticle

Copyright Agreement Statement

The corresponding author has to submit Copyright Agreement form after the article is accepted for publication in order to warrant that this contribution is original and that he/she has full power to make this grant. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors.

 

The author(s) grant Current Applied Science and Technology a non-exclusive, irrevocable, royalty-free license to publish, reproduce, distribute, and archive the article in print and electronic form with effect if and when the article is accepted for publication. In the event that the article is withdrawn prior to acceptance or is declined, this agreement shall have no effect, and no party shall be bound by it.

 

The author(s) retain copyright of this article, including but not limited to the right to reproduce and distribute the article, to include it in a thesis or book, and to post it on an institutional or personal repository, provided that the original publication in Current Applied Science and Technology is properly cited.

 

 

 

References

[1] Belter, P. A., Cussler, E. L. and Hu, W.-S. 1988. Bioseparations: Downstream Processing for Biotechnology, John Wiley & Sons, New York.
[2] Dwyer, J. L. 1984. Bio/Technology, 2, 957.
[3] Bonnerjea, J., Oh, S., Hoare, M., and Dunnill, P. 1986. Biotechnology, 4, 954.
[4] Asenjo, J. A. 1988. The rational design of large scale protein separation sequences. Paper presented at the 196th ACS National Meeting, MBTD division, Los Angeles, 25-30.
[5] Pharmacia, 1983. Scale up to process chromatography. Guide to Design, Pharmacia, Uppsala, Sweden.
[6] Faber, C., Hobley, T., Mollerup, J., Thomas, O., Kaasgaard, S. 2008. Factors affecting the solubility of Bacillus halmapalus α-amylase. Chem. Eng. Process. 47,1007-1017.
[7] Saul, R. T., Scholtz, J. M., Pace, C. N., 2008. Measuring and increasing protein solubility. J. Pharm. Sci. 97,4155-4166.
[8] Retailleau, P., Ries-Kautt, M., Ducruix, A. 1997. No salting-in of lysozyme chloride observed at low ionic strength over a large range of pH. Biophys. J. 71, 2156-2163.
[9] Robert, A., Donahue, Jr., Bebee, R. L. 1999. BL21-SI competent cells for protein expression in E. coli. Focus. 21, 49-51.
[10] Liu, J. W., Boucher, Y., Stokes, H. W., Ollis, D. L. 2006. Improving protein solubility: The use of the Escherichia coli dihydrofolate reductase gene as a fusion reporter. Prot. Expr. Purr. 47, 258-263.
[11] Green. A. A. 1932.Studies in the physical chemistry of the proteins. Phys. Chem. Protein. 10, 47-66.
[12] Green, A. 1931. Studies in the physical chemistry of the proteins. VIII. The solubility of hemoglobin in concentrated salt solutions: a study of the salting-out of proteins. J. Biol. Chem. 93, 495-516.
[13] Green, A. 1931. Studies in the physical chemistry of the proteins. IX. The effect of electrolytes on the solubility of hemoglobin in solutions of varying hydrogen ion activity with a note on the comparable behavior of casein. J. Biol. Chem. 93, 517-542.